PTC Therapeutics, Inc. (PTCT)
71.02
+1.20
(+1.72%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Total Assets (Quarterly) : 3.250B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.250B |
| March 31, 2026 | 2.869B |
| December 31, 2025 | 2.911B |
| September 30, 2025 | 2.644B |
| June 30, 2025 | 2.634B |
| March 31, 2025 | 2.655B |
| December 31, 2024 | 1.717B |
| September 30, 2024 | 1.842B |
| June 30, 2024 | 1.916B |
| March 31, 2024 | 1.790B |
| December 31, 2023 | 1.903B |
| September 30, 2023 | 1.260B |
| June 30, 2023 | 1.338B |
| March 31, 2023 | 1.609B |
| December 31, 2022 | 1.706B |
| September 30, 2022 | 1.576B |
| June 30, 2022 | 1.804B |
| March 31, 2022 | 1.800B |
| December 31, 2021 | 1.938B |
| September 30, 2021 | 2.007B |
| June 30, 2021 | 2.059B |
| March 31, 2021 | 2.112B |
| December 31, 2020 | 2.208B |
| September 30, 2020 | 2.181B |
| June 30, 2020 | 1.477B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.546B |
| December 31, 2019 | 1.624B |
| September 30, 2019 | 1.641B |
| June 30, 2019 | 1.292B |
| March 31, 2019 | 1.284B |
| December 31, 2018 | 1.119B |
| September 30, 2018 | 1.029B |
| June 30, 2018 | 511.77M |
| March 31, 2018 | 379.41M |
| December 31, 2017 | 391.65M |
| September 30, 2017 | 367.72M |
| June 30, 2017 | 383.08M |
| March 31, 2017 | 248.64M |
| December 31, 2016 | 269.34M |
| September 30, 2016 | 288.18M |
| June 30, 2016 | 305.56M |
| March 31, 2016 | 335.23M |
| December 31, 2015 | 368.04M |
| September 30, 2015 | 396.10M |
| June 30, 2015 | 273.82M |
| March 31, 2015 | 299.52M |
| December 31, 2014 | 333.22M |
| September 30, 2014 | 220.80M |
| June 30, 2014 | 237.56M |
| March 31, 2014 | 255.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.103B |
| Madrigal Pharmaceuticals, Inc. | 1.245B |
| Protagonist Therapeutics, Inc. | 885.54M |
| Biogen, Inc. | 32.09B |
| BioMarin Pharmaceutical, Inc. | 11.72B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.416B |
| Shareholders Equity (Quarterly) | -165.36M |
| Debt to Equity Ratio | -4.212 |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | -0.90% |